Clinical Trials Opportunities

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

CSTI-500 as a Potential Treatment for PWS
*****THIS STUDY HAS COMPLETED ENROLLMENT***** Study Purpose This is an open-label, single-center, Phase 1 study to evaluate the PK and safety of a 10 mg single oral dose of CSTI-500, a triple monoamine reuptake inhibitor (TRI), in people with PWS....
ARD-101 as a Potential Treatment for PWS
Study Purpose HERO is a Phase 3, double blind study sponsored by Aardvark Therapeutics to investigate the effects of ARD-101 on hyperphagia-related behavior in people with Prader-Willi Syndrome. This study will compare ARD-101 to a placebo to see if ARD-101...
Research Opportunities for People with Schaaf-Yang Syndrome
Understanding the Pathophysiology of Schaaf-Yang Syndrome to Improve Care and Treatment Options Dr. Fleischer at Southern Illinois University School of Medicine, in conjunction with Dr. Schaaf from Heidelberg University in Germany, is conducting a study entitled, “Understanding the Pathophysiology of...